National Antimicrobial Resistance Monitoring System Program Subcommittee of the Science Advisory Board to the Food and Drug Administration; Notice of Public Meeting, 13289 [E7-5153]

Agencies

• Food and Drug Administration
• DEPARTMENT OF HEALTH AND HUMAN SERVICES

[Federal Register Volume 72, Number 54 (Wednesday, March 21, 2007)]
[Notices]
[Page 13289]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-5153]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


National Antimicrobial Resistance Monitoring System Program 
Subcommittee of the Science Advisory Board to the Food and Drug 
Administration; Notice of Public Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of public meeting.

-----------------------------------------------------------------------

    The Food and Drug Administration (FDA) is announcing the following 
public meeting: Science Board to the FDA National Antimicrobial 
Resistance Monitoring System (NARMS) Program Subcommittee meeting. The 
topic to be discussed is the National Antimicrobial Resistance 
Monitoring System (NARMS) Program. The subcommittee will provide advice 
to the Science Advisory Board to FDA regarding the NARMS program.
    Date and Time: The public meeting will be held on April 10, 2007, 
beginning at 9 a.m.
    Location: The DoubleTree Hotel and Executive Meeting Center, 1750 
Rockville Pike, Rockville, MD 20852.
    Contact: Carlos Pena, Office of Science and Health Coordination, 
Office of the Commissioner (HF-33), Food and Drug Administration, 5600 
Fishers Lane (for express delivery, rm. 14B-08), Rockville, MD 20857, 
301-827-3340, e-mail: Carlos.Pena@fda.hhs.gov.
    Agenda: The subcommittee will evaluate the NARMS program and 
address four questions relevant to the continued success of the program 
including:
    (1) Are there inherent biases in the sampling strategies employed 
in NARMS? If so, how can they be improved to ensure that the data and 
interpretation are scientifically sound given current resources?
    (2) Are there epidemiological and/or microbiological research 
studies that would better serve the goals of NARMS and the regulatory 
work of FDA?
    (3) Are current plans for data harmonization and reporting 
appropriate? If not, what are the top priorities for advancing 
harmonized reporting? and
    (4) Are the current NARMS international activities adequate to 
address the worldwide spread of antimicrobial-resistant foodborne 
bacteria?
    The subcommittee will discuss the NARMS Program and hear comments 
on the NARMS Program, including oral presentations from the public on 
scope, strengths, weaknesses, and areas for improvement.
    Registration and Requests for Oral Presentations: Send registration 
information (including name, title, firm name, address, telephone and 
fax number, and e-mail address), and written material and requests to 
make oral presentations, to the contact person on or before March 28, 
2007. Interested persons may present data, information, or views, 
orally or in writing, on the issues pending before this subcommittee. 
Written submissions may be made to the contact person on or before 
March 28, 2007. Oral presentations from the public will be scheduled to 
begin at 11 a.m. on April 10, 2007. Those desiring to make formal oral 
presentations should notify the contact person and submit a brief 
statement of the general nature of the evidence or arguments they wish 
to present, the names and addresses of proposed participants, and an 
indication of the approximate time requested to make their presentation 
on or before March 20, 2007. Time allotted for each presentation may be 
limited. If the number of registrants requesting to speak is greater 
than can be reasonably accommodated during the scheduled open public 
hearing session, FDA may conduct a lottery to determine the speakers 
for the scheduled open pubic hearing session. The contact person will 
notify interested person regarding their request to speak by March 20, 
2007.
    If you need special accommodations due to a disability, please 
notify the hotel (301-468-1100) at least 7 days in advance of the 
meeting.
    Transcripts: Transcripts of the public meeting may be requested in 
writing from the Freedom of Information Office (HFI-35), Food and Drug 
Administration, 5600 Fishers Lane, rm. 6-30, Rockville, MD 20857, 
approximately 15 working days after the meeting at a cost of 10 cents 
per page.

    Dated: March 14, 2007.
Randall W. Lutter,
Associate Commissioner for Policy and Planning.
[FR Doc. E7-5153 Filed 3-20-07; 8:45 am]
BILLING CODE 4160-01-S